Editor's note: Seeking Alpha is proud to welcome Mining The Data as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.Analyst’s Disclosure: I/we have a beneficial long position in the shares of ADM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation fo ...

Core Viewpoint - Archer Daniels Midland Company (ADM) is expected to report declines in both earnings and revenues for the first quarter of 2025, with significant challenges in its Ag Services & Oilseeds segment contributing to this underperformance [1][4]. Financial Estimates - The Zacks Consensus Estimate for ADM's earnings is 69 cents per share, reflecting a 52.7% decrease from the same quarter last year, with a 2.8% decline in the consensus mark over the past 30 days [2]. - Revenue estimates are set at $20.7 billion, indicating a 5.3% drop year-over-year [2]. Segment Performance - The Ag Services & Oilseeds segment is projected to see operating profits decline by approximately 50% in Q1 2025, with revenue estimates at $16.1 billion and adjusted operating profit at $454 million, representing year-over-year declines of 6.4% and 47.5%, respectively [7]. - In the Carbohydrate Solutions segment, operating profit is anticipated to decrease by 5-15% compared to the previous year [6]. - The Nutrition segment is expected to show slight growth, with revenue estimates at $1.9 billion, up 0.5% year-over-year, and operating profit anticipated to remain flat sequentially [8]. Market Conditions - ADM is facing tough market conditions, including sluggishness in the agriculture cycle, increased cost inflation, and weak demand for vegetable oil, which have negatively impacted its Crushing subsegment [4][5]. - The refining margins in the Refined Products and Other segment are under pressure due to increased supply of low-carbon intensity feedstock and weak demand from food customers in North America [5]. Valuation Perspective - ADM is currently trading at a forward 12-month price-to-earnings ratio of 11.01x, which is below its five-year high of 18.93x and the industry average of 14.14x, suggesting it offers compelling value for investors [11]. - Over the past three months, ADM's shares have declined by 3.5%, compared to a 7.2% decline in the industry [12].

FBIF从不只是枯燥的演讲，我们希望在分享丰富干货的同时，您还能感受到乐趣，享受与现场嘉宾共同 放松的时光。今年，我们精心设计 12大互动环节 ，特邀 近30位不同领域的行业专家 ，不仅充满趣 味，而且更具深度，远超您的预期！ 话不多说，让我们一同揭开精彩的面纱！ 饮料创新论坛 【互动研讨一】FB IF2025 【中国植物地图发布】 【时间】 5月8日 14:40-15:10 【地点】 饮料创新论坛 植物饮料正在加速从边缘走向核心。它不再是被贴上"健康"标签的功能饮品附属品，而是成为 连接无 糖化、功能化与消费分层 的重要入口。在原料透明度、成分结构与文化价值被重新审视的今天，植物 正从"配角"走向"主角"。 这一趋势背后，是行业对中国原料体系认知的重新建立。 为此，FBIF特别发布——《FBIF中国植物地图》。以"药食同源"为基础视角，首次系统梳理全国34个 省市区的代表性可食植物资源，涵盖 野菜、中草药、特殊本草 三大板块，构建出一套面向行业的 原料 灵感数据库 ，也是一份连接配方设计、风味创新与文化表达的资源底图。在今天，当饮品行业开始 从"甜"走向"清"、从"刺激"走向"调理"，植物不只是被动被使用的 ...

Group 1 - The core viewpoint of the article is the comprehensive analysis of the high-purity citric acid market, including its growth trends, applications, and competitive landscape from 2020 to 2031 [2][3][4]. Group 2 - The high-purity citric acid market is categorized into different product types, including citric acid granules and powder, with distinct growth trends projected for 2020, 2025, and 2031 [2][3]. - The applications of high-purity citric acid span across food and beverages, pharmaceuticals and personal care, detergents and cleaners, among others, with specific growth trends outlined [2][3][4]. Group 3 - The overall development status of the high-purity citric acid industry highlights key characteristics, influencing factors, and barriers to entry [3][4]. - The supply and demand dynamics for high-purity citric acid globally and in China are forecasted from 2020 to 2030, detailing production capacity, output, and utilization rates [3][4][5]. Group 4 - The competitive landscape of the high-purity citric acid market is analyzed, focusing on major manufacturers' market shares, sales volumes, and revenue from 2020 to 2024 [4][5][6]. - The report includes a detailed examination of the market structure, including the distribution of production capacities and the ranking of leading companies by revenue [4][5][6]. Group 5 - The analysis of different product types and applications of high-purity citric acid includes sales volumes and revenue projections for both global and Chinese markets from 2020 to 2030 [5][6][7]. - The report also discusses the pricing trends of high-purity citric acid across various applications and product types [5][6][7]. Group 6 - The industry development environment is assessed, including trends, driving factors, and the regulatory landscape affecting the high-purity citric acid market in China [6][7][8]. - The supply chain analysis provides insights into the global industry chain, key raw materials, and major downstream customers [6][7][8].

Root for the Underdog. Comment below all on your favorite, least favorite, or curiosity stock tickers to make them eligible for inclusion in future FA follower reports. He is the leader of the investing group The Dividend Dog Catcher , where he shares a minimum of one new dividend stock idea per week with focus on yield or extraordinary financial circumstances. All ideas are archived and available after weekly announcement. Learn more Seeking Alpha's Disclosure: Past performance is no guarantee of future re ...

证券研究报告·行业动态 国际金价再创新高，国内市场炼 焦煤稳中偏弱运行 核心观点 1）美财政部欲重估黄金储备价值，国际金价再创新高。黄金市场 于上周见顶回调后又再度突破前高，连续两周创下历史新高纪 录，国际经济及政治层面因素的叠加是驱动黄金市场不断走强的 主要原因。而短期黄金市场多头情绪也在价格的持续走高中变得 更加谨慎，高位回调风险正在累积。 物流供应链：国际金价再创新高，国内市场炼焦煤稳中偏弱运行 美财政部欲重估黄金储备价值，国际金价再创新高。黄金市场于 上周见顶回调后又再度突破前高，连续两周创下历史新高纪录， 国际经济及政治层面因素的叠加是驱动黄金市场不断走强的主 要原因。而短期黄金市场多头情绪也在价格的持续走高中变得更 加谨慎，高位回调风险正在累积。由于近期对于美国财政部重估 黄金储备价值以应对持续扩大的赤字规模的讨论增多，这一举动 也被市场理解为特朗普政府为缓解外界对美国黄金储备真实性 产生的质疑。 国内市场炼焦煤稳中偏弱运行。现国内主流煤矿目前已全面复产 且产量递增，个别矿因井下受限暂未恢复正常生产，下月产量会 有明显恢复。随着焦炭连续降价九轮，中间洗煤及贸易企业谨慎 观望，部分焦企利润已有不同程 ...

Core Insights - The report titled "Microbiome Collaboration and Licensing Deals 2016-2024" provides a comprehensive overview of 244 microbiome deals announced since 2016, including financial terms and links to deal records [2][4][5] - It offers unprecedented access to microbiome deals made by leading biopharma companies, detailing the motivations and structures behind these agreements [3][4] Report Scope - The report analyzes contract agreements to facilitate due diligence, covering deal trends, financial terms, and a directory of deals organized by company, deal type, and therapeutic target [6][7] - It includes insights into the payment structures, exclusivity rights, and responsibilities for commercialization and development within microbiome deals [8][12] Trends and Analysis - The report highlights trends in microbiome deal-making in the biopharma industry, showcasing leading deals by value and identifying the most active dealmakers [8][10] - It provides a detailed analysis of microbiome deals over the years, including upfront payments, milestone payments, and royalty rates [12][12] Key Topics Covered - The report is structured into several chapters, including an executive summary, trends in microbiome deal-making, leading deals, and a comprehensive directory of microbiome contracts [9][10] - It also addresses key contractual clauses, jurisdictional preferences, and boilerplate clauses that vary across different deals [11]

Group 1 - The primary goal of the "High Income DIY Portfolios" Marketplace service is to achieve high income with low risk and capital preservation [1] - The service provides DIY investors with essential information and portfolio/asset allocation strategies aimed at creating stable, long-term passive income with sustainable yields [1] - The portfolios are specifically designed for income investors, including retirees or near-retirees, and include seven different portfolios: 3 buy-and-hold, 3 rotational portfolios, and a 3-bucket NPP model portfolio [1] Group 2 - The offerings include two high-income portfolios, two dividend growth investing (DGI) portfolios, and a conservative NPP strategy portfolio characterized by low drawdowns and high growth potential [1]

Financial Performance - Revenues for the year ended December 31, 2024, were $85,530 million, a decrease of 8.5% from $93,935 million in 2023[342] - Gross profit decreased to $5,778 million in 2024 from $7,513 million in 2023, reflecting a decline of 23.1%[342] - Net earnings attributable to controlling interests fell to $1,800 million in 2024, down 48.3% from $3,483 million in 2023[342] - The company reported a comprehensive income of $1,278 million in 2024, down from $3,485 million in 2023, indicating a decline of 63.3%[344] - Net earnings for 2024 were $1,779 million, a decrease of 48.7% from $3,466 million in 2023[350] - Net cash provided by operating activities decreased to $2,790 million in 2024 from $4,460 million in 2023, representing a decline of 37.5%[350] - The Company reported a closing balance of redeemable non-controlling interests of $253 million as of December 31, 2024, down from $320 million in 2023[417] - The Company’s net earnings for 2024 were $2.036 billion, down 17% from $2.452 billion in 2023[501] Assets and Liabilities - Total assets decreased to $53,271 million in 2024 from $54,631 million in 2023, reflecting a reduction of 2.5%[348] - The fair value of long-term debt decreased to $7,055 million in 2024 from $8,557 million in 2023, with a market risk of $271 million due to increased corporate bond interest rates[337] - The fair value of total assets as of December 31, 2024, was $10.066 billion, compared to $10.104 billion in 2023, indicating a slight decrease[1] - The fair value of total liabilities as of December 31, 2024, was $1.714 billion, down from $2.421 billion in 2023, showing a significant reduction[1] - The total long-term debt, including current maturities, was $8.254 billion as of December 31, 2024, slightly down from $8.260 billion in 2023[514] - The fair value of the Company's long-term debt, excluding current portion, was estimated at $7.1 billion as of December 31, 2024[515] Cash Flow and Investments - Cash and cash equivalents decreased to $611 million in 2024 from $1,368 million in 2023, a decline of 55.3%[348] - Net cash used in investing activities rose to $2,702 million in 2024 compared to $1,496 million in 2023, indicating an increase of 80.8%[350] - The total cash, cash equivalents, restricted cash, and restricted cash equivalents at the end of 2024 was $3,924 million, down from $5,390 million in 2023, a decrease of 27.3%[350] - The Company had $13.0 billion in lines of credit as of December 31, 2024, with $9.1 billion unused[518] - The Company utilized $2.0 billion of its $2.8 billion accounts receivable securitization program as of December 31, 2024[520] Expenses and Costs - The company incurred asset impairment, exit, and restructuring costs of $545 million in 2024, compared to $342 million in 2023[342] - Research and development costs for the year ended December 31, 2024, were $269 million, an increase from $256 million in 2023 and $216 million in 2022[410] - Aggregate amortization expense for intangible assets was $266 million in 2024, an increase from $234 million in 2023[513] - Total compensation expense for stock option grants and related awards was $74 million in 2024, a decrease from $112 million in 2023[523] Acquisitions and Goodwill - The company acquired Revela Foods, Fuerst Day Lawson, PT Trouw Nutrition Indonesia, and Totally Natural Solutions for a total cash consideration of $948 million in 2024[1] - Goodwill recorded from acquisitions amounted to $557 million, with $373 million expected to be tax-deductible[1] - The Company recorded a goodwill impairment charge of $137 million in 2023, primarily related to the Animal Nutrition reporting unit[509] Market and Risk Management - The company has established metrics to monitor market risk exposure, including volumetric limits and value-at-risk (VaR) limits, with VaR calculations monitored weekly[332] - The average position for commodity risk showed a fair value of $168 million in 2024, with a market risk of $17 million from a hypothetical 10% adverse price change[333] - The Company hedged between 12% and 31% of its monthly corn grind over the past 12 months, with designated hedges representing between 9% to 26% of anticipated monthly grind for the next 12 months as of December 31, 2024[478] - The company hedged between 41% and 74% of its anticipated monthly natural gas consumption over the past 12 months, with designated hedges representing between 35% and 50% for the next 12 months as of December 31, 2024[480] Stock and Dividends - Share repurchases amounted to $2,327 million in 2024, down from $2,673 million in 2023, a reduction of 12.9%[350] - Cash dividends paid increased to $985 million in 2024, compared to $977 million in 2023, marking a rise of 0.8%[350] Other Financial Metrics - The Company recorded bad debt expense of $(16) million, $6 million, and $88 million for the years ended December 31, 2024, 2023, and 2022, respectively[372] - The closing balance for estimated uncollectible accounts decreased to $167 million in 2024 from $215 million in 2023[373] - Total inventories as of December 31, 2024, were $11,572 million, a decrease from $11,957 million in 2023[375] - The Company capitalized interest on major construction projects in progress of $32 million for both 2024 and 2023[395]

Group 1 - iREIT+HOYA Capital focuses on income-producing asset classes that provide sustainable portfolio income, diversification, and inflation hedging [1] - The service offers a free two-week trial for potential investors to explore exclusive income-focused portfolios [1] Group 2 - The author emphasizes a cautious approach towards overvalued stocks, suggesting that opportunities will arise when market conditions change [2] - The investment strategy is centered on defensive stocks with a medium- to long-term investment horizon [2]